Phosphoinositide 3-kinase in Health and Disease [recurso electrónico] : Volume 2 / edited by Christian Rommel, Bart Vanhaesebroeck, Peter K. Vogt.

Por: Rommel, Christian [editor.]Colaborador(es): Vanhaesebroeck, Bart [editor.] | Vogt, Peter K [editor.] | SpringerLink (Online service)Tipo de material: TextoTextoSeries Current Topics in Microbiology and Immunology ; 347Editor: Berlin, Heidelberg : Springer Berlin Heidelberg : Imprint: Springer, 2011Descripción: X, 306 p. online resourceTipo de contenido: text Tipo de medio: computer Tipo de portador: online resourceISBN: 9783642148163Tema(s): Medicine | Oncology | Biomedicine | Cancer ResearchFormatos físicos adicionales: Printed edition:: Sin títuloClasificación CDD: 614.5999 Clasificación LoC:RC261-271Recursos en línea: Libro electrónicoTexto En: Springer eBooksResumen: From humble beginnings over 25 years ago as a lipid kinase activity associated with certain oncoproteins, PI3K (phosphoinositide 3-kinase) has been catapulted to the forefront of drug development in cancer, immunity and thrombosis, with the first clinical trials of PI3K pathway inhibitors now in progress. Here the authors give a brief overview of some key discoveries in the PI3K area and their impact, and include thoughts on the current state of the field, and where it could go from here
Star ratings
    Valoración media: 0.0 (0 votos)
Existencias
Tipo de ítem Biblioteca actual Colección Signatura Copia número Estado Fecha de vencimiento Código de barras
Libro Electrónico Biblioteca Electrónica
Colección de Libros Electrónicos RC261 -271 (Browse shelf(Abre debajo)) 1 No para préstamo 374866-2001

From humble beginnings over 25 years ago as a lipid kinase activity associated with certain oncoproteins, PI3K (phosphoinositide 3-kinase) has been catapulted to the forefront of drug development in cancer, immunity and thrombosis, with the first clinical trials of PI3K pathway inhibitors now in progress. Here the authors give a brief overview of some key discoveries in the PI3K area and their impact, and include thoughts on the current state of the field, and where it could go from here

19

Con tecnología Koha